| Trial ID: | L1379 |
| Source ID: | NCT03286712
|
| Associated Drug: |
Renogen
|
| Title: |
The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Anemia|Complication of Peritoneal Dialysis
|
| Interventions: |
DRUG: Renogen
|
| Outcome Measures: |
Primary: The effect of correction of anemia on the flow mediated-dilatation of the brachial artery, We will measure the baseline hemoglobin level and the status of the flow mediated-dilatation of the brachial artery. We will assess the status of hemoglobin level and the flow mediated dilatation at the end of the study and show assess its correlation., 3 months | Secondary: The effect of generic erythropoietin alpha (Renogen) on the hemoglobin level, We will assess if the erythropoietin alpha (Renogen) is effective in maintaining the target hemoglobin level of the study every month. Included in the assessment are the abrupt increase or decrease of the hemoglobin level, 3 months|The effect of Epoietin alpha on blood pressure, We will monitor the average baseline blood pressure of the patient at baseline. During the study period of 3 months, blood pressure of the patients will also be monitored if there is increase of blood pressure from baseline, 3 months
|
| Sponsor/Collaborators: |
Sponsor: National Kidney and Transplant Institute, Philippines
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-10
|
| Completion Date: |
2017-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-09-18
|
| Locations: |
Department of Adult Nephrology; National Kidney and Transplant Institute, Quezon City, Metro Manila, 1101, Philippines
|
| URL: |
https://clinicaltrials.gov/show/NCT03286712
|
